Input 2020.12.22 06:00
“Demand for diagnostic kits will continue” for vaccine development by overseas pharmaceutical companies–
–
The recent reports of global pharmaceutical companies such as Pfizer developing a vaccine for Corona 19 are also being accepted as a good news in the diagnostic kit industry. The export of diagnostic kits is also expected to exceed 3 trillion won within the year.
According to the Ministry of Food and Drug Safety on the 22nd, the export of corona 19 diagnostic kits in Korea in November was estimated to be 546 million dollars. It increased by 32.52% from the previous month, October. As a result, the cumulative exports until November of this year amounted to $2,272 billion, or about 2.5 trillion won.
In the first quarter of this year, the export of corona 19 diagnostic kits in Korea, which was only 25 million dollars, reached 220 million dollars in April and has maintained an increase or decrease of 100 million dollars, and continues to increase for the fourth month from August to November. . Starting at $280 million in August, it is changing its exports every month from September ($390 million) and October ($412 million) to November. An official in the diagnostic kit industry predicted, “With the recent global spread of Corona 19, annual exports may reach the level of 3 trillion won.”
In fact, the number of corona19 confirmed cases in the world is continuously increasing. The number of corona 19 confirmed cases in the world, which was around 900,000 in the first quarter, recorded 3 million in April and exceeded 10 million in June. After that, it recorded a record in July (18 million) and August (25 million), and reached 63 million in November. According to the international statistics website World Omometer, the number of corona19 confirmed cases in the world exceeded 70 million in December, and as of this day, it is 7 million.
The domestic pharmaceutical and bio industry is also actively jumping into the Corona 19 diagnostic kit market. As of the end of May, there were 73 corona19 diagnostic kits that were licensed for export from the Ministry of Food and Drug Safety, but at the end of November, it has more than tripled to 221. As there are companies waiting for permission applications, industry forecasts will increase further during this month.
The domestic diagnostic kit industry predicts that December will continue to increase in exports of domestic-made Corona 19 diagnostic kits. Celltrion (068270)This month, through Celltrion USA, it signed a contract to exclusively supply a Corona 19 antigen rapid kit worth about 240 billion won to’Prime Healthcare Distributors’, a specialized wholesale distributor in New York, USA. In the same month, GC Green Cross MS also signed a contract to export a Corona 19 antigen diagnostic kit to Hungary with a scale of about 13.9 billion won.
The number of confirmed cases in India, which imported the most domestic Corona 19 diagnostic kits until November this year, continues to increase. Of the total exports of $546 million, India was the largest importer of domestic-made Corona 19 diagnostic kits, accounting for 15.6%, with $355 million. On the 19th (local time), the number of corona19 confirmed cases exceeded 10 million. After the US, the number of corona19 confirmed in the world has exceeded 10 million.
However, there is also a prospect that the news of the development of a COVID-19 vaccine centered on overseas pharmaceutical companies such as AstraZeneca in the UK, Pfizer in the US, and Modena in the United Kingdom could be a variable in the export front of diagnostic kits. After getting the vaccine, the need to check for corona infection may decrease.
However, in the domestic bio industry, full-scale vaccination is expected to increase diagnostic demand. Because corona prevention is possible through a vaccine, aggressive quarantine using a diagnostic kit is possible.
An official of a diagnostic kit company said, “If the Corona 19 vaccine is rapidly distributed, the Genwon kit can be used more actively than the current one to reduce the number of confirmed cases,” he said. “Rather, it may increase rapidly than the current demand.”
In fact, Seegene, the leading Korean Corona 19 diagnostic kit company, said it has exceeded 1 trillion won in annual sales, and predicted an increase in demand for overseas diagnostic kits even after vaccination. A company official said, “Even if the Corona 19 vaccine is commercialized, accurate diagnosis is necessary for reliable quarantine.”
–
– .
